HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dopamine release is impaired in a mouse model of DYT1 dystonia.

Abstract
Early onset torsion dystonia, the most common form of hereditary primary dystonia, is caused by a mutation in the TOR1A gene, which codes for the protein torsinA. This form of dystonia is referred to as DYT1. We have used a transgenic mouse model of DYT1 dystonia [human mutant-type (hMT)1 mice] to examine the effect of the mutant human torsinA protein on striatal dopaminergic function. Analysis of striatal tissue dopamine (DA) and metabolites using HPLC revealed no difference between hMT1 mice and their non-transgenic littermates. Pre-synaptic DA transporters were studied using in vitro autoradiography with [(3)H]mazindol, a ligand for the membrane DA transporter, and [(3)H]dihydrotetrabenazine, a ligand for the vesicular monoamine transporter. No difference in the density of striatal DA transporter or vesicular monoamine transporter binding sites was observed. Post-synaptic receptors were studied using [(3)H]SCH-23390, a ligand for D(1) class receptors, [(3)H]YM-09151-2 and a ligand for D(2) class receptors. There were again no differences in the density of striatal binding sites for these ligands. Using in vivo microdialysis in awake animals, we studied basal as well as amphetamine-stimulated striatal extracellular DA levels. Basal extracellular DA levels were similar, but the response to amphetamine was markedly attenuated in the hMT1 mice compared with their non-transgenic littermates (253 +/- 71% vs. 561 +/- 132%, p < 0.05, two-way anova). These observations suggest that the mutation in the torsinA protein responsible for DYT1 dystonia may interfere with transport or release of DA, but does not alter pre-synaptic transporters or post-synaptic DA receptors. The defect in DA release as observed may contribute to the abnormalities in motor learning as previously documented in this transgenic mouse model, and may contribute to the clinical symptoms of the human disorder.
AuthorsAygul Balcioglu, Mee-Ohk Kim, Nutan Sharma, Jang-Ho Cha, Xandra O Breakefield, David G Standaert
JournalJournal of neurochemistry (J Neurochem) Vol. 102 Issue 3 Pg. 783-8 (Aug 2007) ISSN: 0022-3042 [Print] England
PMID17550429 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Dopamine Plasma Membrane Transport Proteins
  • Ligands
  • Molecular Chaperones
  • Receptors, Dopamine
  • TOR1A protein, human
  • Dopamine
Topics
  • Animals
  • Binding, Competitive (physiology)
  • Corpus Striatum (metabolism, physiopathology)
  • Disease Models, Animal
  • Dopamine (analysis, metabolism)
  • Dopamine Plasma Membrane Transport Proteins (analysis, metabolism)
  • Dystonia Musculorum Deformans (genetics, metabolism, physiopathology)
  • Genetic Predisposition to Disease (genetics)
  • Humans
  • Ligands
  • Mice
  • Mice, Transgenic
  • Molecular Chaperones (genetics)
  • Mutation
  • Presynaptic Terminals (metabolism)
  • Radioligand Assay
  • Receptors, Dopamine (analysis, metabolism)
  • Synaptic Transmission (genetics)
  • Transgenes

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: